ROS1 and adenocarcinoma: In particular, ROS1 should be sought not only in adenocarcinomas, but also in tumors with mixed histology or squamous-cell carcinomas, because an adenocarcinoma component cannot be excluded, especially in never-smokers or younger (<50 years) patients [15].